PNPLA3 and Hepatic fibrosis: As recently reported by Gabriel-Medina et al. (2022), if a genetic risk factor, such as PNPLA3 rs738409, coexists with T2D, a major metabolic driver of NAFLD progression, advanced liver fibrosis may result even more frequently [35].